Comparison of the Efficacy of Different Biologic Agents in Preventing Postoperative Endoscopic Recurrence of Crohn's Disease

La inmunoterapia posquirúrgica ayudó a las personas con cáncer de vejiga de riesgo alto a vivir sin cáncer por más tiempo

En un estudio del NCI, se observó que administrar pembrolizumab a los pacientes después de la cirugía para el cáncer de vejiga con invasión

Systematic review of metastatic Crohn's disease: clinical features, demographics, and treatment approaches

Background Metastatic Crohn’s disease (MCD), also known as cutaneous Crohn’s disease and genital Crohn’s disease, is a rare cutaneous manife

<![CDATA[Reducing Recurrence in C Difficile Infection]]>

Phage Therapy Shows Promise Against Crohn's-Driven E. coli in Mice

Researchers have developed a bacteriophage therapy that neutralizes inflammatory E. coli and boosts corticosteroid efficacy in a mouse model

FDA Approves Subcutaneous Isatuximab for Multiple Myeloma

The FDA approved the subcutaneous (SC) administration of the anti-CD38 antibody isatuximab-irfc (Sarclisa) in multiple myeloma, based on non

Clinical trial finds existing drug dupilumab may treat rare GI disease eosinophilic gastritis

A clinical trial supported by the RDCRN found an existing drug called dupilumab may help treat eosinophilic gastritis.